Ireland
--:--IST
Active, not recruiting Observational

Efficacy of Combining Caudal Epidural Steroid With Ganglion Impar Block in Chronic Coccydynia

NCT07200765 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2020-01-01
Last updated
2025-10-01

Condition(s) studied

Caudal Epidural BlockCoccygodyniaCoccydynia

Study summary

Coccydynia refers to pain localized to the tailbone (coccygeal) region. Initial management is conservative-nonsteroidal anti-inflammatory drugs (NSAIDs), use of a seat cushion, and physical therapy-yet a proportion of patients remain symptomatic and subsequently pursue interventional options. The ganglion impar block (GIB), originally used to treat perineal cancer pain, is now recognized as an effective approach for perineal and coccygeal pain of both malignant and benign etiologies. Caudal epidural steroid injection (CESI) is also employed, either as monotherapy or in conjunction with other treatments; however, its precise role in coccydynia has not been clearly defined. Evidence directly comparing these injections is limited, and whether the combination confers superiority over GIB alone remains unresolved.

In this retrospective study, we will compare GIB alone versus GIB combined with CESI in adults treated for chronic coccydynia refractory to noninterventional management and evaluate any incremental benefit of the combination.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥18 years * Chronic coccydynia \>3 months * Inadequate response to conservative treatments * Written informed consent documented for the procedure (per records) Exclusion Criteria: * Active infection on the injection date. * History of lumbar or coccygeal surgery * Allergy to local anesthetics or contrast media * Coagulopathy / anticoagulant therapy contraindicating the procedure * Inadequate follow-up documentation * Injection performed to a different region during the indexed procedure

Primary outcome measure(s)

  • Change in NRS-11 pain score from baseline to 6 months — Baseline and 6 months post-procedure
    Within-participant change in pain intensity (ΔNRS = 6-month NRS-11 minus baseline NRS-11); negative values indicate improvement. NRS-11: 0=no pain, 10=worst pain.

Trial sites (1)

FacilityCityRegionStatus
Mersin University Faculty of Medicine, Department of Algology Mersin Mersin
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07200765 on ClinicalTrials.gov ↗ ← All trials in Turkey